Exelixis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.About EXEL
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
CEOMichael M. Morrissey
CEOMichael M. Morrissey
Employees1,310
Employees1,310
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded1994
Founded1994
Employees1,310
Employees1,310
EXEL Key Statistics
Market cap6.99B
Market cap6.99B
Price-Earnings ratio36.67
Price-Earnings ratio36.67
Dividend yield—
Dividend yield—
Average volume1.93M
Average volume1.93M
High today$23.76
High today$23.76
Low today$23.32
Low today$23.32
Open price$23.50
Open price$23.50
Volume1.56M
Volume1.56M
52 Week high$24.34
52 Week high$24.34
52 Week low$18.08
52 Week low$18.08
EXEL News
Investor's Business Daily 4d
Exelixis Getting Closer To Key Technical Benchmark - Investor's Business DailyExelixis (EXEL) had its Relative Strength (RS) Rating upgraded from 69 to 75 Tuesday — a welcome improvement, but still short of the 80 or better score you look...
Simply Wall St 5d
Exelixis, Inc.'s Earnings Haven't Escaped The Attention Of Investors - Simply Wall StExelixis, Inc.'s ( ) price-to-earnings (or "P/E") ratio of 32x might make it look like a strong sell right now compared to the market in the United States, wher...
Analyst ratings
68%
of 22 ratingsBuy
68.2%
Hold
27.3%
Sell
4.5%